Article metrics

Download PDFPDF

Original research
Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea

 

Online download statistics by month:

Online download statistics by month: July 2021 to December 2022

AbstractFullPdf
Jul 2021584577179
Aug 202122822859
Sep 202116416454
Oct 202112911948
Nov 202115914072
Dec 2021858138
Jan 2022958436
Feb 2022867924
Mar 2022797446
Apr 202210310032
May 202213012539
Jun 20221019534
Jul 2022777335
Aug 2022917628
Sep 2022948930
Oct 2022939161
Nov 2022766944
Dec 2022645327
Total24382317886